Plante Moran Financial Advisors, LLC Biogen Inc. Transaction History

Plante Moran Financial Advisors, LLC

  • $1.17 Billion
  • Q3 2024

A detailed history of Plante Moran Financial Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 37 shares of BIIB stock, worth $5,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 17 117.65%
Holding current value
$5,913
Previous $3,000 133.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$189.07 - $236.8 $3,781 - $4,736
20 Added 117.65%
37 $7,000
Q1 2024

May 09, 2024
SELL
$212.02 - $267.71 $1,484 - $1,873
-7 Reduced 29.17%
17 $3,000
Q4 2023

Feb 05, 2024
BUY
$222.59 - $267.94 $1,558 - $1,875
7 Added 41.18%
24 $6,000
Q2 2023

Aug 07, 2023
SELL
$275.25 - $318.06 $30,277 - $34,986
-110 Reduced 86.61%
17 $4,000
Q1 2022

May 06, 2022
SELL
$193.77 - $244.14 $19,764 - $24,902
-102 Reduced 44.54%
127 $27,000
Q4 2021

Feb 09, 2022
SELL
$223.92 - $287.77 $7,389 - $9,496
-33 Reduced 12.6%
229 $55,000
Q3 2021

Nov 08, 2021
BUY
$282.99 - $369.05 $13,583 - $17,714
48 Added 22.43%
262 $74,000
Q1 2021

May 13, 2021
SELL
$242.95 - $284.63 $14,577 - $17,077
-60 Reduced 21.9%
214 $60,000
Q4 2020

Feb 09, 2021
SELL
$236.26 - $355.63 $4,961 - $7,468
-21 Reduced 7.12%
274 $67,000
Q3 2020

Nov 12, 2020
SELL
$264.77 - $305.71 $12,179 - $14,062
-46 Reduced 13.49%
295 $84,000
Q2 2020

Aug 10, 2020
SELL
$258.66 - $342.55 $6,725 - $8,906
-26 Reduced 7.08%
341 $91,000
Q1 2020

May 07, 2020
BUY
$268.85 - $341.04 $22,583 - $28,647
84 Added 29.68%
367 $116,000
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $5,501 - $7,601
-25 Reduced 8.12%
283 $84,000
Q3 2019

Nov 13, 2019
BUY
$217.44 - $243.88 $8,915 - $9,999
41 Added 15.36%
308 $71,000
Q2 2019

Aug 13, 2019
SELL
$219.29 - $241.72 $3,947 - $4,350
-18 Reduced 6.32%
267 $62,000
Q1 2019

May 13, 2019
SELL
$216.71 - $338.96 $2,383 - $3,728
-11 Reduced 3.72%
285 $67,000
Q4 2018

Jan 29, 2019
SELL
$278.5 - $352.75 $18,102 - $22,928
-65 Reduced 18.01%
296 $89,000
Q3 2018

Nov 09, 2018
BUY
$293.51 - $383.83 $19,665 - $25,716
67 Added 22.79%
361 $128,000
Q2 2018

Jul 26, 2018
SELL
$257.52 - $306.91 $13,391 - $15,959
-52 Reduced 15.03%
294 $85,000
Q1 2018

May 01, 2018
BUY
$260.13 - $367.91 $8,064 - $11,405
31 Added 9.84%
346 $95,000
Q3 2017

Nov 08, 2017
BUY
$281.15 - $329.69 $88,562 - $103,852
315
315 $99,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email